Literature DB >> 3324405

Fetal tissue transplantation, bone marrow transplantation and prospective gene therapy in severe immunodeficiencies and enzyme deficiencies.

J L Touraine1, M G Roncarolo, C Royo, F Touraine.   

Abstract

The successful development of fetal tissue transplantation has resulted in therapeutical solutions for patients with a variety of diseases. Fetal liver transplants as well as bone marrow transplants, can completely cure patients with severe combined immunodeficiency disease. These transplants can also be applied to treat other types of immunodeficiency, hemopathies, and inborn errors of metabolism, in association with immunosuppressive therapy. Despite complete HLA incompatibility between transplanted stem cells and host cells, functional activities of donor-derived T-lymphocytes are not restricted. In severe forms of Di George syndrome, immunological reconstitution can be obtained by fetal thymus transplantation. It is expected that, in the near future, pure stem cell transplants and gene transplants will develop and will provide remarkable solutions for the therapy of a large number of diseases.

Entities:  

Mesh:

Year:  1987        PMID: 3324405     DOI: 10.1007/978-94-009-3365-1_8

Source DB:  PubMed          Journal:  Thymus        ISSN: 0165-6090


  5 in total

Review 1.  Transplantation of fetal cells and tissue: an overview.

Authors:  A Fine
Journal:  CMAJ       Date:  1994-11-01       Impact factor: 8.262

2.  Chimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cells.

Authors:  R Bacchetta; B A Vandekerckhove; J L Touraine; M Bigler; S Martino; L Gebuhrer; J E de Vries; H Spits; M G Roncarolo
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

Review 3.  Human intrathymic development: a selective approach.

Authors:  J Plum; M De Smedt; G Leclercq; T Taghon; T Kerre; B Vandekerckhove
Journal:  Semin Immunopathol       Date:  2008-10-17       Impact factor: 9.623

4.  The place of fetal liver transplantation in the treatment of inborn errors of metabolism.

Authors:  J L Touraine; S Laplace; F Rezzoug; K Sanhadji; P Veyron; C Royo; I Maire; M T Zabot; M T Vanier; M O Rolland
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

5.  Antigen recognition by MHC-incompatible cells of a human mismatched chimera.

Authors:  M G Roncarolo; H Yssel; J L Touraine; R Bacchetta; L Gebuhrer; J E De Vries; H Spits
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.